A detailed analysis of Zenas BioPharma, Inc.’s quarter follows shortly on AlphaStreet.
This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.
Breaking News
Zenas BioPharma, Inc. (ZBIO) Reports a Net Loss for Q4 FY25
Zenas BioPharma, Inc. (ZBIO) reported Q4 2025 GAAP loss of $1.39 per share, a wider loss than the -$1.19 estimate (16.8% wider).
Zenas BioPharma, Inc. (ZBIO) reported Q4 2025 GAAP loss of $1.39 per share, a wider loss than the -$1.19 estimate (16.8% wider).
ADVERTISEMENT